8-methoxymethyl-3-isobutyl-1-methylxanthine has been researched along with 9-(2-hydroxy-3-nonyl)adenine in 2 studies
Studies (8-methoxymethyl-3-isobutyl-1-methylxanthine) | Trials (8-methoxymethyl-3-isobutyl-1-methylxanthine) | Recent Studies (post-2010) (8-methoxymethyl-3-isobutyl-1-methylxanthine) | Studies (9-(2-hydroxy-3-nonyl)adenine) | Trials (9-(2-hydroxy-3-nonyl)adenine) | Recent Studies (post-2010) (9-(2-hydroxy-3-nonyl)adenine) |
---|---|---|---|---|---|
33 | 0 | 13 | 428 | 1 | 33 |
Protein | Taxonomy | 8-methoxymethyl-3-isobutyl-1-methylxanthine (IC50) | 9-(2-hydroxy-3-nonyl)adenine (IC50) |
---|---|---|---|
cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.8 | |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | Homo sapiens (human) | 0.8 | |
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.8 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.8 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hernández, J; Juan-Fita, MJ; Vargas, ML | 2 |
2 other study(ies) available for 8-methoxymethyl-3-isobutyl-1-methylxanthine and 9-(2-hydroxy-3-nonyl)adenine
Article | Year |
---|---|
Comparative actions of diazepam and other phosphodiesterase inhibitors on the effects of noradrenaline in rat myocardium.
Topics: Adenine; Animals; Cyclic AMP; Diazepam; Dose-Response Relationship, Drug; Drug Synergism; Female; In Vitro Techniques; Isoenzymes; Male; Milrinone; Myocardial Contraction; Norepinephrine; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Rolipram; Xanthines | 2003 |
The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Exonucleases; Female; Glucagon; Heart Ventricles; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase I; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Quinolones; Rats; Rats, Sprague-Dawley; Ventricular Function; Xanthines | 2005 |